• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Nucleoside excretion in breast cancer: comparison with other biochemical tumour-index-substances.

作者信息

Coombes R C, Powles T J, Gehrke C W, Waalkes T P, Neville A M

出版信息

Invest Cell Pathol. 1979 Jan-Mar;2(1):11-4.

PMID:511604
Abstract

[We have measured four urinary nucleosides (dimethylguanosine, 1-methylinosine, pseudouridine and beta-aminoisobutyric acid)in patients with benign breast disease and patients with early and advanced breast cancer in order to assess their value as tumour-index-substances. We compared the results with other biochemical indices of breast cancer and sought and correlations between these indices. The results indicate that few abnormalities occurred in patients without overt metastases and these did not predict early relapse. In those with metastatic disease, dimethylguanosine excretion was most frequently elevated. Correlations were observed between some of the nucleosides and lysozyme and alpha1-antirypsin.

摘要

相似文献

1
Nucleoside excretion in breast cancer: comparison with other biochemical tumour-index-substances.
Invest Cell Pathol. 1979 Jan-Mar;2(1):11-4.
2
Urinary excretion of modified nucleosides in chronic myelogenous leukemia.慢性粒细胞白血病中修饰核苷的尿排泄情况。
J Lab Clin Med. 1983 May;101(5):783-92.
3
Gas chromatography/mass spectrometric analysis of urinary nucleosides in cancer patients; potential of modified nucleosides as tumour markers.癌症患者尿液核苷的气相色谱/质谱分析;修饰核苷作为肿瘤标志物的潜力
Rapid Commun Mass Spectrom. 1993 Jun;7(6):427-34. doi: 10.1002/rcm.1290070605.
4
Biological markers in breast carcinoma--clinical correlations with pseudouridine, N2,N2-dimethylguanosine, and 1-methylinosine.
J Surg Oncol. 1980;14(3):267-73. doi: 10.1002/jso.2930140313.
5
A quantitative approach to determining disease response during therapy using multiple biologic markers: application to carcinoma of the breast.一种使用多种生物标志物在治疗期间确定疾病反应的定量方法:应用于乳腺癌
Cancer. 1978 May;41(5):1685-703. doi: 10.1002/1097-0142(197805)41:5<1685::aid-cncr2820410507>3.0.co;2-9.
6
Biochemically detectable tumor markers in urine of bladder cancer patients.
Cancer Res. 1977 Aug;37(8 Pt 2):2872-4.
7
Relationship of urinary excretion of modified nucleosides to disease status in childhood acute lymphoblastic leukemia.
J Natl Cancer Inst. 1983 Aug;71(2):269-73.
8
The urinary excretion of nucleosides of ribonucleic acid by patients with advanced cancer.
Cancer. 1975 Aug;36(2):390-8. doi: 10.1002/1097-0142(197508)36:2<390::aid-cncr2820360214>3.0.co;2-c.
9
Urinary excretion by cancer patients of the nucleosides N-dimethylguanosine, 1-methylinosine, and pseudouridine.癌症患者尿液中核苷N - 二甲基鸟苷、1 - 甲基肌苷和假尿苷的排泄情况。
J Natl Cancer Inst. 1973 Jul;51(1):271-4. doi: 10.1093/jnci/51.1.271.
10
Urinary modified nucleosides as tumor markers in cancer of the urinary organs or female genital tract.
Urol Res. 1985;13(5):213-8. doi: 10.1007/BF00261578.